Gary R Peterson

Title: Innovations of Gary R Peterson in Vaccine Development

Introduction

Gary R Peterson is an accomplished inventor based in Omaha, NE (US). He has made significant contributions to the field of vaccine development, particularly through his innovative work on recombinant attenuated clostridium organisms. His research has the potential to impact public health by providing new avenues for vaccine creation.

Latest Patents

Gary R Peterson holds a patent for "Recombinant attenuated clostridium organisms and vaccine." This invention discloses attenuated organisms that express a substantially nontoxic alpha-toxin. The expressed alpha-toxin is a deletion mutein that, relative to the alpha-toxin of the mature alpha-toxin of strain 13, is missing at least nine consecutive amino acid residues, including His. The patent also covers the use of such attenuated organisms as vaccines, showcasing his innovative approach to combating diseases.

Career Highlights

Throughout his career, Gary has been associated with Intervet Inc., where he has furthered his research and development efforts. His work has not only contributed to the scientific community but has also paved the way for advancements in veterinary and human medicine.

Collaborations

Gary R Peterson has collaborated with notable colleagues, including Mark D Cochran and Stephen V Lair. These partnerships have enhanced his research capabilities and have led to significant advancements in the field.

Conclusion

Gary R Peterson's innovative work in vaccine development exemplifies the importance of research in public health. His contributions through his patent on recombinant attenuated clostridium organisms highlight the potential for new vaccines that can improve health outcomes.